PDB Short entry for 1GG5 HEADER OXIDOREDUCTASE 12-JUL-00 1GG5 TITLE CRYSTAL STRUCTURE OF A COMPLEX OF HUMAN NAD[P]H-QUINONE OXIDOREDUCTASE TITLE 2 AND A CHEMOTHERAPEUTIC DRUG (E09) AT 2.5 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: NAD(P)H DEHYDROGENASE [QUINONE] 1; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: QUINONE REDUCTASE, DT-DIAPHORASE; COMPND 5 EC: 1.6.99.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FLAVOPROTEIN, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.FAIG,M.A.BIANCHET,S.WINSKI,R.HARGREAVES,C.J.MOODY,A.R.HUDNOTT, AUTHOR 2 D.ROSS,L.M.AMZEL REVDAT 4 27-DEC-23 1GG5 1 REMARK REVDAT 3 12-NOV-14 1GG5 1 KEYWDS REVDAT 2 24-FEB-09 1GG5 1 VERSN REVDAT 1 12-SEP-01 1GG5 0 JRNL AUTH M.FAIG,M.A.BIANCHET,S.WINSKI,R.HARGREAVES,C.J.MOODY, JRNL AUTH 2 A.R.HUDNOTT,D.ROSS,L.M.AMZEL JRNL TITL STRUCTURE-BASED DEVELOPMENT OF ANTICANCER DRUGS: COMPLEXES JRNL TITL 2 OF NAD(P)H:QUINONE OXIDOREDUCTASE 1 WITH CHEMOTHERAPEUTIC JRNL TITL 3 QUINONES. JRNL REF STRUCTURE V. 9 659 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11587640 JRNL DOI 10.1016/S0969-2126(01)00636-0 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.FAIG,M.A.BIANCHET,P.TALALAY,S.CHEN,S.WINSKI,D.ROSS, REMARK 1 AUTH 2 L.M.AMZEL REMARK 1 TITL STRUCTURES OF RECOMBINANT HUMAN AND MOUSE NAD(P)H:QUINONE REMARK 1 TITL 2 OXIDOREDUCTASES: SPECIES COMPARISON AND STRUCTURAL CHANGES REMARK 1 TITL 3 WITH SUBSTRATE BINDING AND RELEASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 3177 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.050585797 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.A.BIANCHET,C.FOSTER,M.FAIG,P.TALALAY,L.M.AMZEL REMARK 1 TITL STRUCTURE AND MECHANISM OF CYTOSOLIC QUINONE REDUCTASES REMARK 1 REF BIOCHEM.SOC.TRANS. V. 27 610 1999 REMARK 1 REFN ISSN 0300-5127 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.FOSTER,M.A.BIANCHET,P.TALALAY,Q.ZHAO,L.M.AMZEL REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN QUINONE REDUCTASE TYPE 2, A REMARK 1 TITL 2 METALLOPROTEIN REMARK 1 REF BIOCHEMISTRY V. 38 9881 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI990799V REMARK 1 REFERENCE 4 REMARK 1 AUTH R.LI,M.A.BIANCHET,P.TALALAY,L.M.AMZEL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF NAD(P)H:QUINONE REMARK 1 TITL 2 REDUCTASE, A FLAVOPROTEIN INVOLVED IN CANCER CHEMOPROTECTION REMARK 1 TITL 3 AND CHEMOTHERAPY: MECHANISM OF TWO-ELECTRON REDUCTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 92 8846 1995 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.23 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.3 REMARK 3 NUMBER OF REFLECTIONS : 35866 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 3679 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 79.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4592 REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE : 0.3510 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 540 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8692 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 296 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.37000 REMARK 3 B22 (A**2) : 3.62000 REMARK 3 B33 (A**2) : 2.76000 REMARK 3 B12 (A**2) : -5.93000 REMARK 3 B13 (A**2) : -0.75000 REMARK 3 B23 (A**2) : 4.95000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.35 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.49 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.220 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.970 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.30 REMARK 3 BSOL : 17.81 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GG5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-00. REMARK 100 THE DEPOSITION ID IS D_1000001484. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRANDEIS - B4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46509 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 43.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.7 REMARK 200 DATA REDUNDANCY : 1.680 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.7900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 23.3 REMARK 200 DATA REDUNDANCY IN SHELL : 1.39 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.16900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30 % PEG 3350, 200 MM NAACETATE, 12-24 REMARK 280 MICROM FAD, 100MM NA-TRICINE PH 8.5, PH 8.50, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9700 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 1 CG1 CG2 REMARK 470 VAL B 1 CG1 CG2 REMARK 470 VAL C 1 CG1 CG2 REMARK 470 VAL D 1 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO B 136 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 123 -51.76 84.13 REMARK 500 TYR A 132 -123.01 54.18 REMARK 500 ILE A 175 -61.48 -107.44 REMARK 500 SER A 191 59.92 24.38 REMARK 500 PRO A 196 152.23 -48.28 REMARK 500 LEU A 230 53.49 -69.53 REMARK 500 HIS A 257 53.35 -114.23 REMARK 500 LYS A 261 -159.96 -107.65 REMARK 500 ARG A 272 101.92 69.91 REMARK 500 GLU B 123 -36.34 76.82 REMARK 500 TYR B 132 -128.01 46.83 REMARK 500 ILE B 175 -68.18 -94.44 REMARK 500 SER B 191 67.99 29.20 REMARK 500 LEU B 230 57.24 -68.37 REMARK 500 SER B 254 -166.51 -164.38 REMARK 500 HIS B 257 55.17 -110.42 REMARK 500 ARG B 272 99.49 70.01 REMARK 500 SER C 51 -179.99 -170.19 REMARK 500 PHE C 106 26.96 47.78 REMARK 500 GLU C 123 -39.93 79.94 REMARK 500 TYR C 132 -128.91 34.31 REMARK 500 SER C 191 62.06 37.85 REMARK 500 HIS C 257 59.35 -110.77 REMARK 500 THR C 265 141.95 -39.30 REMARK 500 ASP C 266 51.33 27.49 REMARK 500 ARG C 272 94.37 71.72 REMARK 500 THR D 56 41.11 -91.04 REMARK 500 PHE D 106 17.43 50.83 REMARK 500 GLU D 123 -29.40 75.69 REMARK 500 ALA D 130 74.54 -114.01 REMARK 500 TYR D 132 -124.54 50.37 REMARK 500 SER D 173 -66.47 -92.78 REMARK 500 ILE D 175 -64.45 -103.73 REMARK 500 SER D 191 59.81 27.80 REMARK 500 HIS D 257 54.76 -110.39 REMARK 500 LYS D 261 -167.76 -109.75 REMARK 500 ARG D 272 96.40 73.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD C 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD D 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E09 C 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E09 D 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E09 A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E09 B 704 DBREF 1GG5 A 1 273 UNP P15559 NQO1_HUMAN 2 274 DBREF 1GG5 B 1 273 UNP P15559 NQO1_HUMAN 2 274 DBREF 1GG5 C 1 273 UNP P15559 NQO1_HUMAN 2 274 DBREF 1GG5 D 1 273 UNP P15559 NQO1_HUMAN 2 274 SEQRES 1 A 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 A 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 A 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 A 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 A 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 A 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 A 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 A 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 A 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 A 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 A 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 A 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 A 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 A 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 A 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 A 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 A 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 A 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 A 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 A 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 A 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 B 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 B 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 B 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 B 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 B 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 B 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 B 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 B 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 B 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 B 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 B 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 B 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 B 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 B 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 B 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 B 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 B 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 B 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 B 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 B 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 B 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 C 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 C 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 C 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 C 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 C 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 C 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 C 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 C 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 C 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 C 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 C 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 C 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 C 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 C 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 C 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 C 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 C 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 C 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 C 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 C 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 C 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS SEQRES 1 D 273 VAL GLY ARG ARG ALA LEU ILE VAL LEU ALA HIS SER GLU SEQRES 2 D 273 ARG THR SER PHE ASN TYR ALA MET LYS GLU ALA ALA ALA SEQRES 3 D 273 ALA ALA LEU LYS LYS LYS GLY TRP GLU VAL VAL GLU SER SEQRES 4 D 273 ASP LEU TYR ALA MET ASN PHE ASN PRO ILE ILE SER ARG SEQRES 5 D 273 LYS ASP ILE THR GLY LYS LEU LYS ASP PRO ALA ASN PHE SEQRES 6 D 273 GLN TYR PRO ALA GLU SER VAL LEU ALA TYR LYS GLU GLY SEQRES 7 D 273 HIS LEU SER PRO ASP ILE VAL ALA GLU GLN LYS LYS LEU SEQRES 8 D 273 GLU ALA ALA ASP LEU VAL ILE PHE GLN PHE PRO LEU GLN SEQRES 9 D 273 TRP PHE GLY VAL PRO ALA ILE LEU LYS GLY TRP PHE GLU SEQRES 10 D 273 ARG VAL PHE ILE GLY GLU PHE ALA TYR THR TYR ALA ALA SEQRES 11 D 273 MET TYR ASP LYS GLY PRO PHE ARG SER LYS LYS ALA VAL SEQRES 12 D 273 LEU SER ILE THR THR GLY GLY SER GLY SER MET TYR SER SEQRES 13 D 273 LEU GLN GLY ILE HIS GLY ASP MET ASN VAL ILE LEU TRP SEQRES 14 D 273 PRO ILE GLN SER GLY ILE LEU HIS PHE CYS GLY PHE GLN SEQRES 15 D 273 VAL LEU GLU PRO GLN LEU THR TYR SER ILE GLY HIS THR SEQRES 16 D 273 PRO ALA ASP ALA ARG ILE GLN ILE LEU GLU GLY TRP LYS SEQRES 17 D 273 LYS ARG LEU GLU ASN ILE TRP ASP GLU THR PRO LEU TYR SEQRES 18 D 273 PHE ALA PRO SER SER LEU PHE ASP LEU ASN PHE GLN ALA SEQRES 19 D 273 GLY PHE LEU MET LYS LYS GLU VAL GLN ASP GLU GLU LYS SEQRES 20 D 273 ASN LYS LYS PHE GLY LEU SER VAL GLY HIS HIS LEU GLY SEQRES 21 D 273 LYS SER ILE PRO THR ASP ASN GLN ILE LYS ALA ARG LYS HET FAD A 601 53 HET E09 A 703 21 HET FAD B 602 53 HET E09 B 704 21 HET FAD C 603 53 HET E09 C 701 21 HET FAD D 604 53 HET E09 D 702 21 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM E09 3-HYDROXYMETHYL-5-AZIRIDINYL-1METHYL-2-[1H-INDOLE-4,7- HETNAM 2 E09 DIONE]-PROPANOL FORMUL 5 FAD 4(C27 H33 N9 O15 P2) FORMUL 6 E09 4(C15 H18 N2 O4) FORMUL 13 HOH *104(H2 O) HELIX 1 1 SER A 16 LYS A 32 1 17 HELIX 2 2 LEU A 41 ASN A 45 1 5 HELIX 3 3 SER A 51 ASP A 54 5 4 HELIX 4 4 ASP A 61 PHE A 65 5 5 HELIX 5 5 GLN A 66 GLY A 78 1 13 HELIX 6 6 SER A 81 ALA A 94 1 14 HELIX 7 7 PRO A 109 PHE A 120 1 12 HELIX 8 8 MET A 131 GLY A 135 5 5 HELIX 9 9 GLY A 152 SER A 156 5 5 HELIX 10 10 ASP A 163 SER A 173 1 11 HELIX 11 11 SER A 191 THR A 195 5 5 HELIX 12 12 PRO A 196 LEU A 211 1 16 HELIX 13 13 PRO A 224 LEU A 227 5 4 HELIX 14 14 ASN A 231 GLY A 235 5 5 HELIX 15 15 LYS A 239 LYS A 247 1 9 HELIX 16 16 SER B 16 LYS B 32 1 17 HELIX 17 17 LEU B 41 ASN B 45 1 5 HELIX 18 18 SER B 51 ASP B 54 5 4 HELIX 19 19 GLN B 66 GLY B 78 1 13 HELIX 20 20 SER B 81 ALA B 94 1 14 HELIX 21 21 PRO B 109 PHE B 120 1 12 HELIX 22 22 MET B 131 GLY B 135 5 5 HELIX 23 23 SER B 151 SER B 156 5 6 HELIX 24 24 ASP B 163 SER B 173 1 11 HELIX 25 25 SER B 191 THR B 195 5 5 HELIX 26 26 PRO B 196 GLU B 212 1 17 HELIX 27 27 ASN B 213 GLU B 217 5 5 HELIX 28 28 PRO B 224 LEU B 227 5 4 HELIX 29 29 ASN B 231 GLY B 235 5 5 HELIX 30 30 LYS B 239 LYS B 247 1 9 HELIX 31 31 SER C 16 LYS C 32 1 17 HELIX 32 32 TYR C 42 ASN C 45 5 4 HELIX 33 33 SER C 51 ASP C 54 5 4 HELIX 34 34 GLN C 66 GLY C 78 1 13 HELIX 35 35 SER C 81 ALA C 94 1 14 HELIX 36 36 PRO C 109 PHE C 120 1 12 HELIX 37 37 MET C 131 GLY C 135 5 5 HELIX 38 38 SER C 151 SER C 156 5 6 HELIX 39 39 ASP C 163 SER C 173 1 11 HELIX 40 40 LEU C 176 GLY C 180 5 5 HELIX 41 41 SER C 191 THR C 195 5 5 HELIX 42 42 PRO C 196 GLU C 212 1 17 HELIX 43 43 ASN C 213 GLU C 217 5 5 HELIX 44 44 PRO C 224 LEU C 227 5 4 HELIX 45 45 LYS C 239 LYS C 247 1 9 HELIX 46 46 SER D 16 LYS D 32 1 17 HELIX 47 47 SER D 51 ASP D 54 5 4 HELIX 48 48 ASP D 61 PHE D 65 5 5 HELIX 49 49 GLN D 66 GLY D 78 1 13 HELIX 50 50 SER D 81 ALA D 94 1 14 HELIX 51 51 PRO D 109 PHE D 120 1 12 HELIX 52 52 MET D 131 GLY D 135 5 5 HELIX 53 53 SER D 151 SER D 156 5 6 HELIX 54 54 ASP D 163 SER D 173 1 11 HELIX 55 55 LEU D 176 GLY D 180 5 5 HELIX 56 56 SER D 191 THR D 195 5 5 HELIX 57 57 PRO D 196 LEU D 211 1 16 HELIX 58 58 GLU D 212 GLU D 217 5 6 HELIX 59 59 PRO D 224 LEU D 227 5 4 HELIX 60 60 LYS D 239 LYS D 247 1 9 SHEET 1 A 5 GLU A 35 ASP A 40 0 SHEET 2 A 5 ARG A 4 LEU A 9 1 N ALA A 5 O GLU A 35 SHEET 3 A 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 A 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 A 5 GLN A 182 VAL A 183 1 O GLN A 182 N ALA A 142 SHEET 1 B 5 GLU A 35 ASP A 40 0 SHEET 2 B 5 ARG A 4 LEU A 9 1 N ALA A 5 O GLU A 35 SHEET 3 B 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 B 5 LYS A 141 THR A 147 1 O LYS A 141 N VAL A 97 SHEET 5 B 5 GLN A 187 THR A 189 1 N GLN A 187 O LEU A 144 SHEET 1 C 5 GLU B 35 ASP B 40 0 SHEET 2 C 5 ARG B 4 LEU B 9 1 N ALA B 5 O GLU B 35 SHEET 3 C 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 C 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 C 5 GLN B 182 VAL B 183 1 O GLN B 182 N ALA B 142 SHEET 1 D 5 GLU B 35 ASP B 40 0 SHEET 2 D 5 ARG B 4 LEU B 9 1 N ALA B 5 O GLU B 35 SHEET 3 D 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 D 5 LYS B 141 THR B 147 1 O LYS B 141 N VAL B 97 SHEET 5 D 5 GLN B 187 THR B 189 1 N GLN B 187 O LEU B 144 SHEET 1 E 5 GLU C 35 ASP C 40 0 SHEET 2 E 5 ARG C 4 LEU C 9 1 N ALA C 5 O GLU C 35 SHEET 3 E 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 E 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 E 5 GLN C 182 VAL C 183 1 O GLN C 182 N ALA C 142 SHEET 1 F 5 GLU C 35 ASP C 40 0 SHEET 2 F 5 ARG C 4 LEU C 9 1 N ALA C 5 O GLU C 35 SHEET 3 F 5 LEU C 96 PRO C 102 1 O LEU C 96 N LEU C 6 SHEET 4 F 5 LYS C 141 THR C 147 1 O LYS C 141 N VAL C 97 SHEET 5 F 5 GLN C 187 THR C 189 1 N GLN C 187 O LEU C 144 SHEET 1 G 5 GLU D 35 ASP D 40 0 SHEET 2 G 5 ARG D 4 LEU D 9 1 N ALA D 5 O GLU D 35 SHEET 3 G 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 G 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 G 5 GLN D 182 VAL D 183 1 O GLN D 182 N ALA D 142 SHEET 1 H 5 GLU D 35 ASP D 40 0 SHEET 2 H 5 ARG D 4 LEU D 9 1 N ALA D 5 O GLU D 35 SHEET 3 H 5 LEU D 96 PRO D 102 1 O LEU D 96 N LEU D 6 SHEET 4 H 5 LYS D 141 THR D 147 1 O LYS D 141 N VAL D 97 SHEET 5 H 5 GLN D 187 THR D 189 1 N GLN D 187 O LEU D 144 SITE 1 AC1 22 HIS A 11 THR A 15 SER A 16 PHE A 17 SITE 2 AC1 22 ASN A 18 ALA A 20 PRO A 102 LEU A 103 SITE 3 AC1 22 GLN A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC1 22 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC1 22 ILE A 192 ARG A 200 LEU A 204 GLN C 66 SITE 6 AC1 22 TYR C 67 E09 C 701 SITE 1 AC2 22 HIS B 11 THR B 15 SER B 16 PHE B 17 SITE 2 AC2 22 ASN B 18 ALA B 20 PRO B 102 LEU B 103 SITE 3 AC2 22 GLN B 104 TRP B 105 PHE B 106 THR B 147 SITE 4 AC2 22 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 5 AC2 22 ILE B 192 ARG B 200 LEU B 204 GLN D 66 SITE 6 AC2 22 TYR D 67 E09 D 702 SITE 1 AC3 21 GLN A 66 TYR A 67 E09 A 703 HIS C 11 SITE 2 AC3 21 THR C 15 SER C 16 PHE C 17 ASN C 18 SITE 3 AC3 21 ALA C 20 PRO C 102 LEU C 103 GLN C 104 SITE 4 AC3 21 TRP C 105 PHE C 106 THR C 147 THR C 148 SITE 5 AC3 21 GLY C 149 GLY C 150 TYR C 155 ILE C 192 SITE 6 AC3 21 ARG C 200 SITE 1 AC4 23 GLN B 66 TYR B 67 PRO B 68 E09 B 704 SITE 2 AC4 23 HOH B 716 HIS D 11 THR D 15 SER D 16 SITE 3 AC4 23 PHE D 17 ASN D 18 ALA D 20 PRO D 102 SITE 4 AC4 23 LEU D 103 GLN D 104 TRP D 105 PHE D 106 SITE 5 AC4 23 THR D 147 THR D 148 GLY D 149 GLY D 150 SITE 6 AC4 23 TYR D 155 ILE D 192 ARG D 200 SITE 1 AC5 11 TRP A 105 PHE A 106 GLY A 149 GLY A 150 SITE 2 AC5 11 HIS A 161 FAD A 601 PRO C 68 TYR C 126 SITE 3 AC5 11 TYR C 128 GLY C 174 PHE C 178 SITE 1 AC6 10 TRP B 105 PHE B 106 GLY B 149 GLY B 150 SITE 2 AC6 10 HIS B 161 FAD B 602 PRO D 68 TYR D 126 SITE 3 AC6 10 TYR D 128 PHE D 178 SITE 1 AC7 10 PRO A 68 TYR A 126 TYR A 128 GLY A 174 SITE 2 AC7 10 PHE A 178 PHE C 106 GLY C 149 GLY C 150 SITE 3 AC7 10 HIS C 161 FAD C 603 SITE 1 AC8 10 PRO B 68 TYR B 126 TYR B 128 GLY B 174 SITE 2 AC8 10 PHE B 178 PHE D 106 GLY D 149 GLY D 150 SITE 3 AC8 10 HIS D 161 FAD D 604 CRYST1 56.733 55.454 97.205 76.42 77.22 86.45 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017626 -0.001093 -0.003850 0.00000 SCALE2 0.000000 0.018068 -0.004214 0.00000 SCALE3 0.000000 0.000000 0.010832 0.00000